NanoViricides
NNVC
$1.10
Share price
-0.90%
Change (1 day)
-17.29%
Change (1 year)
Categories
NanoViricides (NNVC) - Total assets
Total assets on the balance sheet as of December 2023 : $13.4 M
According to NanoViricides's latest financial reports the company's total assets are $13.4 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
NanoViricides - Total assets on balance sheet (from 2006 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-06-30 | $16.89 M | -28.07% |
| 2022-06-30 | $23.49 M | -22.36% |
| 2021-06-30 | $30.26 M | 26.54% |
| 2020-06-30 | $23.91 M | 77.82% |
| 2019-06-30 | $13.44 M | -27.49% |
| 2018-06-30 | $18.54 M | -31.32% |
| 2017-06-30 | $27 M | -26.29% |
| 2016-06-30 | $36.63 M | -17.09% |
| 2015-06-30 | $44.18 M | 0.75% |
| 2014-06-30 | $43.85 M | 167.32% |
| 2013-06-30 | $16.4 M | 4.98% |
| 2012-06-30 | $15.62 M | 45.28% |
| 2011-06-30 | $10.75 M | 19.64% |
| 2010-06-30 | $8.99 M | 199.62% |
| 2009-06-30 | $3 M | 104.41% |
| 2008-06-30 | $1.46 M | 8.74% |
| 2007-06-30 | $1.35 M | -50.53% |
| 2006-06-30 | $2.72 M | |
| 2005-06-30 | $N/A |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $62.12 B | 463,443.30% | 🇺🇸 USA |
 Merck MRK | $106.67 B | 795,851.41% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $99.03 B | 738,816.00% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $75.11 B | 560,355.75% | 🇬🇧 UK |
 Novavax NVAX | $1.79 B | 13,311.90% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $0.51 B | 3,757.28% | 🇺🇸 USA |